Verum Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.56M Buy
6,156
+1,669
+37% +$389K 0.23% 58
2026
Q1
$1.1M Buy
4,487
+1,327
+42% +$309K 0.21% 63
2025
Q4
$654K Sell
3,160
-356
-10% -$70.4K 0.13% 80
2025
Q3
$652K Sell
3,516
-78
-2% -$13.4K 0.14% 80
2025
Q2
$549K Buy
3,594
+544
+18% +$83.6K 0.13% 91
2025
Q1
$506K Sell
3,050
-674
-18% -$105K 0.14% 86
2024
Q4
$539K Sell
3,724
-192
-5% -$29.8K 0.16% 79
2024
Q3
$635K Buy
3,916
+301
+8% +$48K 0.19% 73
2024
Q2
$528K Sell
3,615
-8
-0.2% -$1.19K 0.17% 77
2024
Q1
$573K Sell
3,623
-464
-11% -$73.9K 0.2% 76
2023
Q4
$641K Sell
4,087
-455
-10% -$69.8K 0.25% 66
2023
Q3
$707K Buy
4,542
+968
+27% +$160K 0.32% 61
2023
Q2
$592K Buy
3,574
+842
+31% +$136K 0.54% 40
2023
Q1
$423K Sell
2,732
-277
-9% -$44.7K 0.45% 41
2022
Q4
$532K Buy
+3,009
New +$520K 0.65% 41

Other funds holding JNJ

Verum Partners's JNJ Position: Q2 2026 in Review

Verum Partners increased its Johnson & Johnson (JNJ) stake by 37% in Q2 2026, buying an estimated $389K and bringing the position to 6,156 shares worth $1.56M. The position accounts for 0.23% of the portfolio, ranked #58.

Verum Partners first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. 1,305 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Verum Partners held 6,156 shares of Johnson & Johnson worth $1.56M as of Q2 2026.
  • Verum Partners bought 1,669 Johnson & Johnson shares in Q2 2026, an estimated $389K.
  • Johnson & Johnson made up 0.23% of Verum Partners's portfolio in Q2 2026, its #58 holding.
  • Verum Partners first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • 1,305 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Verum Partners's 13F filing for Q2 2026, filed 22 Jul 2026.